# Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup

> **NCT00938353** · PHASE3 · TERMINATED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 6 (actual)

## Conditions studied

- Croup

## Interventions

- **DRUG:** beclomethasone dipropionate suspension for nebulisation 800 mcg/2 ml
- **DRUG:** Placebo solution for nebulisation 2 ml

## Key facts

- **NCT ID:** NCT00938353
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** possibility to discriminate the active drug from placebo
- **Last updated:** 2011-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938353, "Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00938353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*